1120738

John A. Phillips, III M.D. — FEI 3015945595

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 27, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Nashville, TN (United States)

Additional Details

Clinical Investigator (CI)